Intracellular pH affects mitochondrial homeostasis in cultured human corneal endothelial cells prepared for cell injection therapy.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 04 2022
Historique:
received: 10 11 2021
accepted: 30 03 2022
pubmed: 17 4 2022
medline: 20 4 2022
entrez: 16 4 2022
Statut: epublish

Résumé

This study aimed to uncover the mechanism responsible for the clinical efficacy of cell injection therapy with fully differentiated cultured cells. Analysis of polarized expression of ion transporters on cultured human corneal endothelial cells (CECs) subpopulations (SPs) was performed. The intracellular pH (pHi) between two CEC SPs, distinct in the proportion of differentiated cells, was measured, and the association with mitochondrial respiration homeostasis was investigated. The effects of the ion transporter inhibition by their selective inhibitors or siRNA transfection were also explored. Na

Identifiants

pubmed: 35428816
doi: 10.1038/s41598-022-10176-1
pii: 10.1038/s41598-022-10176-1
pmc: PMC9012833
doi:

Substances chimiques

Anion Transport Proteins 0
Antiporters 0
RNA, Small Interfering 0
SLC4A11 protein, human 0
Water 059QF0KO0R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6263

Informations de copyright

© 2022. The Author(s).

Références

Prog Mol Biol Transl Sci. 2015;134:79-97
pubmed: 26310151
Am J Physiol Cell Physiol. 2019 Mar 1;316(3):C404-C414
pubmed: 30649921
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4749-61
pubmed: 27607421
Oncotarget. 2016 Apr 19;7(16):21091-113
pubmed: 27049728
J Biol Chem. 2004 Jun 25;279(26):26991-7007
pubmed: 15090545
Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):10
pubmed: 32049346
J Cell Biol. 2016 Nov 7;215(3):345-355
pubmed: 27821494
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2011-2020
pubmed: 28384722
Cell Res. 2017 Sep;27(9):1083-1099
pubmed: 28675158
Hum Mol Genet. 2013 Nov 15;22(22):4579-90
pubmed: 23813972
Am J Pathol. 2010 Nov;177(5):2278-89
pubmed: 20847286
Invest Ophthalmol Vis Sci. 2013 Mar 28;54(3):1887-97
pubmed: 23422828
Eur J Med Chem. 2003 Jun;38(6):547-54
pubmed: 12832126
Redox Biol. 2019 Sep;26:101260
pubmed: 31254733
J Mol Cell Cardiol. 2009 Jun;46(6):998-1007
pubmed: 19318234
Invest Ophthalmol Vis Sci. 2012 Apr 18;53(4):2020-9
pubmed: 22410572
Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):81-91
pubmed: 27773735
Ophthalmology. 2013 Dec;120(12):2428-2435
pubmed: 24246826
Biomed Res Int. 2015;2015:475392
pubmed: 26451371
Exp Eye Res. 2020 Oct;199:108193
pubmed: 32818510
Ophthalmology. 2016 Jul;123(7):1421-7
pubmed: 27108095
Invest Ophthalmol Vis Sci. 2020 Dec 1;61(14):10
pubmed: 33275651
Ophthalmology. 2021 Apr;128(4):504-514
pubmed: 32898516
Prog Retin Eye Res. 2008 Jul;27(4):420-33
pubmed: 18501660
Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5667-71
pubmed: 19608540
Biochem Biophys Res Commun. 2019 Nov 19;519(4):887-893
pubmed: 31561854
Sci Rep. 2017 Jun 22;7(1):4074
pubmed: 28642546
Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4393-402
pubmed: 27564521
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Am J Ophthalmol. 2008 Feb;145(2):222-227
pubmed: 18061137
Mitochondrion. 2017 Sep;36:103-113
pubmed: 28549842
Cornea. 2006 Sep;25(8):886-9
pubmed: 17102661
N Engl J Med. 2018 Mar 15;378(11):995-1003
pubmed: 29539291
J Biol Chem. 2016 Nov 4;291(45):23662-23671
pubmed: 27629415
Hum Mutat. 2018 May;39(5):676-690
pubmed: 29327391
Prog Retin Eye Res. 2003 Jan;22(1):69-94
pubmed: 12597924
Nat Rev Mol Cell Biol. 2010 Jan;11(1):50-61
pubmed: 19997129
Biochem Biophys Res Commun. 2015 May 8;460(3):845-9
pubmed: 25838200
Invest Ophthalmol Vis Sci. 2020 May 11;61(5):47
pubmed: 32455435
J Cell Mol Med. 2010 Apr;14(4):771-94
pubmed: 20015196
Apoptosis. 2013 Dec;18(12):1586-98
pubmed: 23996609
Front Oncol. 2020 Aug 18;10:1561
pubmed: 32974190
J Biol Chem. 1997 Oct 17;272(42):26545-9
pubmed: 9334233
Cell. 2008 Jul 11;134(1):62-73
pubmed: 18614011
Am J Physiol Heart Circ Physiol. 2009 Jan;296(1):H159-70
pubmed: 19011045
Cell Physiol Biochem. 2014;33(1):185-94
pubmed: 24481225
Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4385-92
pubmed: 27564520
Physiol Rev. 2010 Oct;90(4):1271-90
pubmed: 20959616
Am J Physiol Cell Physiol. 2016 Jul 1;311(1):C116-26
pubmed: 27225657

Auteurs

Hideto Deguchi (H)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.

Tomoko Yamashita (T)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.

Nao Hiramoto (N)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.

Yohei Otsuki (Y)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.

Atsushi Mukai (A)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.

Morio Ueno (M)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.

Chie Sotozono (C)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.

Shigeru Kinoshita (S)

Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Junji Hamuro (J)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan. jshimo@koto.kpu-m.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH